RHUMBLINE ADVISERS - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$1,030,061
-0.2%
287,730
+2.9%
0.00%0.0%
Q2 2023$1,031,812
+109901.3%
279,624
-1.3%
0.00%0.0%
Q1 2023$938
-3.1%
283,371
+13.5%
0.00%0.0%
Q4 2022$968
-99.8%
249,595
+1.2%
0.00%0.0%
Q3 2022$599,000
+30.8%
246,593
+6.7%
0.00%0.0%
Q2 2022$458,000
+301.8%
231,114
+257.2%
0.00%
Q1 2021$114,000
-9.5%
64,698
+0.2%
0.00%
Q4 2020$126,000
-10.0%
64,598
+10.3%
0.00%
Q3 2020$140,000
-31.0%
58,570
-15.6%
0.00%
Q2 2020$203,000
+45.0%
69,374
+42.2%
0.00%
Q1 2020$140,000
-24.3%
48,773
+5.2%
0.00%
Q4 2019$185,000
-9.3%
46,364
+1.1%
0.00%
Q3 2019$204,000
+78.9%
45,841
+55.9%
0.00%
Q2 2019$114,000
+32.6%
29,398
+28.9%
0.00%
Q1 2019$86,000
+53.6%
22,799
-2.1%
0.00%
Q4 2018$56,000
-41.7%
23,279
+50.5%
0.00%
Q3 2018$96,000
+33.3%
15,469
-3.7%
0.00%
Q2 2018$72,00016,0600.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 8,793,321$32,447,35411.70%
Velan Capital Investment Management LP 2,726,051$10,059,1289.34%
Altium Capital Management LP 2,380,000$8,782,2006.65%
AWM Investment Company, Inc. 6,017,572$22,204,8413.01%
Caligan Partners LP 847,513$3,127,3231.76%
Perceptive Advisors 11,900,255$43,911,9411.27%
Mesirow Financial Investment Management, Inc. 51,686$190,7210.81%
OBERWEIS ASSET MANAGEMENT INC/ 1,668,700$6,157,5030.75%
TANG CAPITAL MANAGEMENT LLC 1,260,000$4,649,4000.68%
EAM Investors, LLC 883,842$3,261,3770.60%
View complete list of ADMA BIOLOGICS INC shareholders